1.15.1.1	superoxide dismutase	vein	saphenous veins	675625	
1.17.3.2	xanthine oxidase	vein	-	684354	
1.2.1.3	aldehyde dehydrogenase (NAD+)	vein	-	697280, 697845	
2.7.1.137	phosphatidylinositol 3-kinase	vein	-	708145	
2.7.11.30	receptor protein serine/threonine kinase	vein	-	705441	
3.1.3.53	[myosin-light-chain] phosphatase	vein	mesenteric vein, high expression of enzyme with predominance of 3’-exon-excluded, leucine-zipper negative MYPT 1 isoform	663585	
3.4.14.5	dipeptidyl-peptidase IV	vein	in vein DPIV represents 80% of the total Gly-L-Pro-4-nitroanilide-hydrolyzing activity	697386	
3.4.17.23	angiotensin-converting enzyme 2	vein	total vessel wall expression of ACE and ACE2 is similar during all stages of atherosclerosis. The observed ACE2 protein is enzymatically active and activity is lower in the stable advanced atherosclerotic lesions, compared to early and ruptured atherosclerotic lesions	693806	
4.4.1.1	cystathionine gamma-lyase	vein	-	690376